gentleMACS Octo Dissociator with Heaters

The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases intends to award a firm-fixed-price purchase order for a gentleMACS Octo Dissociator with Heaters to Miltenyi Biotec, Inc. under sole-source justification (FAR Part 6.302-1), with award anticipated approximately ten days after the July 1, 2026 notice date. Small businesses, including 8(a), service-disabled veteran-owned, HUBZone, small disadvantaged, veteran-owned, and women-owned small businesses may submit written capability statements by 11:00 p.m. EDT on July 10, 2026 to david.shen@nih.gov demonstrating ability to perform the requirement; the Government reserves discretion to compete the award based on capability statement responses.

The gentleMACS Octo Dissociator is an automated benchtop tissue dissociation system that standardizes workflows for isolating and preparing single-cell suspensions from animal and human tissue samples. The instrument uses controlled mechanical dissociation combined with temperature-regulated enzymatic digestion to process multiple samples simultaneously and generate high-quality suspensions from fresh, frozen, and fixed tissues. It supports processing of rodent, non-human primate, and human tissues while improving reproducibility and reducing hands-on processing time. The system operates exclusively with gentleMACS Tubes or Perfusers in closed systems; tubes feature a unique rotor/stator mechanism for tissue dissociation or homogenization, and perfusers include a peristaltic pump with needles for automated tissue perfusion.

NAICS 334516 (Analytical Laboratory Instrument Manufacturing); PSC 6640 (Laboratory Equipment and Supplies).